Access cutting-edge lung cancer treatment through this clinical trial at a research site in Athens. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Athens at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival prospects for metastatic disease. The purpose of this study is to evaluate the optimized dose, adverse events, and efficacy of livmoniplimab in combination with budigalimab plus chemotherapy versus pembrolizumab plus chemotherapy in participants with untreated metastatic non-squamous non-small cell lung cancer. Livmoniplimab is an investigational drug being developed for the
Sponsor: AbbVie
Check if you qualify for this lung cancer clinical trial in Athens, GA
If you're searching for lung cancer treatment options in Athens, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Athens research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.